McLaughlin B, Daly L, Devlin J G
Department of Endocrinology, Beaumont Hospital, Dublin.
Ir J Med Sci. 1992 Jan;161(1):9-11. doi: 10.1007/BF02984668.
Twenty-two patients with diabetes and hypertension were treated with Doxazosin. An acceptable fall in blood pressure was found with 1 mg. in 50% of patients and 2-8 mgs. in 50%. An increase in HDL cholesterol and a fall in LDL cholesterol levels which reached statistical significance was observed. A small but significant increase in HBA1 levels occurred in the 50% of patients on the higher Doxazosin dose.
22名糖尿病和高血压患者接受了多沙唑嗪治疗。发现1毫克剂量时,50%的患者血压下降幅度可接受;2 - 8毫克剂量时,另外50%的患者血压下降幅度可接受。观察到高密度脂蛋白胆固醇升高和低密度脂蛋白胆固醇水平下降,且达到统计学显著意义。接受较高多沙唑嗪剂量的患者中,有50%的患者糖化血红蛋白水平出现小幅但显著的升高。